In conclusion, through a series of comprehensive analyses—including differential expression analysis, PPI network construction, machine learning, expression level analysis, ROC analysis, and RT-qPCR validation—this study successfully identified two SUMO-related genes (SUMO3 and SEH1L) as potential biomarkers for PD. Here, SEH1L is linked to Parkinson disease.